The latest Investing Matters Podcast episode featuring Jeremy Skillington, CEO of Poolbeg Pharma has just been released. Listen here.

Less Ads, More Data, More Tools Register for FREE

Pin to quick picksKromek Regulatory News (KMK)

Share Price Information for Kromek (KMK)

London Stock Exchange
Share Price is delayed by 15 minutes
Get Live Data
Share Price: 6.80
Bid: 6.60
Ask: 7.00
Change: -0.45 (-6.21%)
Spread: 0.40 (6.061%)
Open: 7.35
High: 7.35
Low: 6.80
Prev. Close: 7.25
KMK Live PriceLast checked at -

Watchlists are a member only feature

Login to your account

Alerts are a premium feature

Login to your account

Appointment of Joint Broker

11 Jan 2018 07:00

RNS Number : 5512B
Kromek Group PLC
11 January 2018
 

11 January 2018 

 

Kromek Group plc

 

("Kromek" or the "Company")

 

Appointment of Joint Broker

 

Kromek (AIM: KMK), a radiation detection technology company focusing on the medical, security and nuclear markets, is pleased to announce the immediate appointment of Cantor Fitzgerald Europe as Joint Broker to the Company. Cenkos Securities will remain as Nominated Adviser and Joint Broker to the Company.

 

For further information, please contact:

 

Kromek Group plc

Arnab Basu, CEO

Derek Bulmer, CFO

 

+44 (0)1740 626 060

Cenkos Securities plc (Nominated Adviser and Joint Broker)

Bobbie Hilliam (NOMAD)

Julian Morse (Sales)

 

+44 (0)20 7397 8900

Cantor Fitzgerald Europe (Joint Broker)

Philip Davies

Will Goode

 

+44 (0)20 7894 7000

Luther Pendragon Ltd (PR)

Harry Chathli

Claire Norbury

Alexis Gore

+44 (0)20 7618 9100

 

About Kromek Group plc

 

Kromek Group plc is a UK technology Group (global HQ in County Durham) and a leading developer of high performance radiation detection products based on cadmium zinc telluride ("CZT") and other advanced technologies. Using its core technology platforms, Kromek designs, develops and produces x-ray and gamma ray imaging and radiation detection products for the medical, security screening and nuclear markets.

 

The Group's products provide high resolution information on material composition and structure and are used in multiple applications, ranging from the identification of cancerous tissues to hazardous materials, such as explosives, and the analysis of radioactive materials.

 

The Group's business model provides a vertically integrated technology offering to customers, from radiation detector materials to finished products or detectors, including software, electronics and application specific integrated circuits ("ASICs").

 

The Group has operations in the UK and US (California and Pennsylvania), and is selling internationally through a combination of distributors and direct OEM sales.

 

Currently, the Group has over one hundred full time employees across its global operations. Further information on Kromek Group is available at www.kromek.com and https://twitter.com/kromekgroup.

This information is provided by RNS
The company news service from the London Stock Exchange
 
END
 
 
MSCSFUEFSFASEEF
Date   Source Headline
1st Dec 20157:00 amRNSKromek enters partnership with CANBERRA Industries
5th Nov 20157:00 amRNSCross Licensing Agreement
23rd Oct 201512:49 pmRNSResult of AGM
8th Oct 20157:00 amRNSDARPA Sole Source Notice
30th Sep 20151:53 pmRNSNotice of AGM and Posting of Annual Report
28th Sep 20152:18 pmRNSBlocklisting Interim Review
28th Sep 20157:00 amRNSAppointment of Sir Peter Williams CBE as Chairman
2nd Sep 20158:56 amRNSHolding(s) in Company
28th Aug 20151:18 pmRNSHolding(s) in Company
28th Aug 201512:13 pmRNSTotal Voting Rights
28th Aug 20159:08 amRNSHolding(s) in Company
26th Aug 20153:59 pmRNSHolding(s) in Company
20th Aug 20158:23 amRNSHolding(s) in Company
17th Aug 201512:11 pmRNSResults of Firm Placing and Open Offer
30th Jul 201512:16 pmRNSDirector Share Purchase
30th Jul 201511:39 amRNSFirm Placing and Open Offer Timetable
30th Jul 20157:01 amRNSFirm Placing and Open Offer to raise up to £11.0m
30th Jul 20157:01 amRNSFinal Results
1st Jul 20155:13 pmRNSHolding(s) in Company
1st Jul 20155:07 pmRNSHolding(s) in Company
18th May 20157:00 amRNSMultiple contract wins with global OEMs
28th Apr 20157:00 amRNSChange of Adviser
17th Apr 20157:00 amRNSKromek awarded further contract by DARPA
17th Apr 20157:00 amRNSBusiness and Trading Update
27th Mar 20157:00 amRNSDirectorate Change
16th Mar 20157:00 amRNSCredit facility with HSBC
10th Feb 20158:56 amRNSBlock Listing Update
9th Feb 20157:00 amRNSGlobal contract wins across all segments
14th Jan 20157:00 amRNSInterim Results
14th Jan 20157:00 amRNSExtension to nuclear detection contract with DARPA
11th Dec 20147:00 amRNSKromek Contract Wins
9th Oct 20149:15 amRNSDirector's Dealing
1st Oct 201411:56 amRNSResult of AGM
22nd Sep 20147:00 amRNSProgress with global OEM contract
10th Sep 20145:46 pmRNSAnnual Report and Accounts and Notice of AGM
28th Aug 20147:00 amRNSFinal Results
4th Aug 20147:00 amRNSContract Win
31st Jul 20147:00 amRNSBlock Listing Update and Additional Listing
22nd Jul 20147:00 amRNSContract Win and Update on Trading
23rd Jun 20147:00 amRNSContract Wins
5th Jun 20147:00 amRNSNew Loan Facility
15th Apr 20147:00 amRNSDirector/PDMR Shareholding
7th Apr 20145:03 pmRNSDirector/PDMR Shareholding
4th Apr 20147:00 amRNSNew Contract Signed in Medical Imaging Market
28th Mar 20147:01 amRNSTrading Statement
27th Feb 20147:00 amRNSNew Orders Received in Medical Imaging
18th Feb 20147:00 amRNSDirectorate Change
30th Jan 20143:56 pmRNSAdditional Listing
8th Jan 20147:00 amRNSHalf Yearly Report
10th Dec 20137:00 amRNSDirectorate Change

Due to London Stock Exchange licensing terms, we stipulate that you must be a private investor. We apologise for the inconvenience.

To access our Live RNS you must confirm you are a private investor by using the button below.

Login to your account

Don't have an account? Click here to register.

Quickpicks are a member only feature

Login to your account

Don't have an account? Click here to register.